– Reuters
Credit Suisse Maintains Underperform on Chemours, Raises Price Target to $27
Credit Suisse analyst John Roberts maintains Chemours (NYSE:CC) with a Underperform and raises the price target from $24 to $27.
Related Posts
Morgan Stanley Maintains Overweight on Datadog, Lowers Price Target to $110
Morgan Stanley analyst Sanjit Singh maintains Datadog (NASDAQ:DDOG) with a Overweight and lowers the price target from $124 to $110.
Dine Brands Analyst Says Underlying Trends Are Bit Difficult To Discern Given Omicron Laps In Recent Months
Raymond James analyst Brian M.Vaccaro reiterated a Market Perform rating on the shares of Dine Brands Global, Inc. (NYSE:DIN). Dine Brands reported a 9.4%…
American Resources’ ReElement Technologies Signs Lithium Offtake And Partnership Agreements With American Lithium Energy Corporation; Co. And Affiliates Intend To Invest Up To $3M Into ALE To Further Align Core Competencies And Growth Objectives
ReElement Technologies will supply high-purity, battery-grade materials for use in American Lithium Energy's battery manufacturing process
The companies will work to co-locate operations within the other's